id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-N-0134-0119,FDA,FDA-1999-N-0134,Risk Assessment and Rick Management Meeting held on 12/04/2003,Other,TR-Transcript,2004-01-15T05:00:00Z,2004,1,,,2008-04-25T00:17:00Z,,0,0,09000064804aecb4
FDA-1999-N-0134-0117,FDA,FDA-1999-N-0134,Risk Assessment and Rick Management Meeting held on 12/04/2003,Other,TR-Transcript,2004-01-15T05:00:00Z,2004,1,,,2008-04-25T00:16:58Z,,0,0,09000064804aecad
FDA-1999-N-0134-0118,FDA,FDA-1999-N-0134,Risk Assessment and Rick Management Meeting held on 12/04/2003,Other,TR-Transcript,2004-01-15T05:00:00Z,2004,1,,,2008-04-25T00:17:00Z,,0,0,09000064804aecb1
FDA-1999-N-0134-0120,FDA,FDA-1999-N-0134,Risk Assessment and Rick Management Meeting held on 12/04/2003,Other,TR-Transcript,2004-01-15T05:00:00Z,2004,1,,,2008-04-25T00:16:58Z,,0,0,09000064804aecb6